Pimavanserin D4 (possibility 2) - Request Quote
Pimavanserin D4 (possibility 2)
| SZ CAT No: | SZ-P058D05 |
| CAS No | NA |
| Mol.F. | C25H30D4FN3O2 |
| Mol.Wt. |
431.6 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pimavanserin D4 (possibility 2) is chemically 1-(Fluorobenzyl)-3-(isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea. Pimavanserin D4 (possibility 2) is supplied with detailed characterization data compliant with regulatory guideline. Pimavanserin D4 (possibility 2) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pimavanserin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Pimavanserin D4 (possibility 2)
Purchase Pimavanserin D4 (possibility 2)
Pimavanserin D4 (possibility 2) suppliers
Pimavanserin D4 (possibility 2) manufacturers
Pimavanserin D4 (possibility 2) price
Order Pimavanserin D4 (possibility 2)
Enquire Pimavanserin D4 (possibility 2)
Pimavanserin D4 (possibility 2) cost
Pimavanserin D4 (possibility 2) Supplier
Pimavanserin D4 (possibility 2) Distributor
Pimavanserin D4 (possibility 2) for Method Validation
Pimavanserin Reference Standard
Pimavanserin D4 (possibility 2) for ANDA Filing
Pimavanserin D4 (possibility 2) for Forced Degradation Studies
Pimavanserin D4 (possibility 2) Identification Standards
Pimavanserin D4 (possibility 2) for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.